
Opinion|Videos|September 23, 2024
Considerations for Dose Modifications
The discussion addresses when dose modifications are typically required in chronic lymphocytic leukemia treatment and identifies the most common reasons for these modifications.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- When do patients typically require dose modification in chronic lymphocytic leukemia (CLL) treatment, and what are the most common reasons for dose modifications in CLL treatments?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
2
Building a CDTM Program Means Starting Small
3
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
4
Pharmacists Can Close the LDL Control Gap in Lipid Care
5
































































































